Morgan Stanley BIOMARIN PHARMACEUTICAL INC Transaction History

Morgan Stanley

4,972,000

Previous 3,582,000 38.81%

Previous $0 NaN%

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	N/A	1,390,000 Added 38.81%	4,972,000 $0
Q2 2025 Aug 15, 2025	SELL	N/A	-5,405,000 Reduced 60.14%	3,582,000 $0
Q1 2025 May 15, 2025	SELL	N/A	-738,000 Reduced 7.59%	8,987,000 $0
Q3 2024 May 14, 2025	SELL	N/A	-640,000 Reduced 6.17%	9,725,000 $0
Q3 2024 Nov 14, 2024	SELL	N/A	-640,000 Reduced 6.17%	9,725,000 $0

Q2 2024 May 14, 2025	BUY	N/A	640,000 Added 6.58%	10,365,000 $0
Q2 2024 Oct 17, 2024	BUY	N/A	60,000 Added 0.58%	10,365,000 $0
Q2 2024 Aug 14, 2024	BUY	N/A	60,000 Added 0.58%	10,365,000 $0
Q1 2024 Oct 17, 2024	SELL	N/A	-60,000 Reduced 0.58%	10,305,000 $0
Q1 2024 Aug 16, 2024	BUY	N/A	780,000 Added 8.19%	10,305,000 $0
Q1 2024 May 15, 2024	BUY	N/A	780,000 Added 8.19%	10,305,000 $0
Q4 2023 Aug 16, 2024	SELL	N/A	-840,000 Reduced 8.1%	9,525,000 $0
Q4 2023 Feb 13, 2024	BUY	N/A	735,000 Added 8.36%	9,525,000 $0
Q3 2023 Nov 15, 2023	BUY	N/A	2,380,000 Added 37.13%	8,790,000 $0
Q2 2023 Aug 14, 2023	BUY	N/A	6,410,000 New	6,410,000 $0
Q4 2022 Feb 14, 2023	BUY	N/A	2,479,000 Added 1697.95%	2,625,000 $0
Q3 2022 Nov 14, 2022	BUY	N/A	80,000 Added 121.21%	146,000 $146,000
Q2 2022 Oct 27, 2022	SELL	N/A	-464,000 Reduced 87.55%	66,000 $66,000
Q2 2022 Aug 15, 2022	SELL	N/A	-464,000 Reduced 87.55%	66,000 $66,000
Q1 2022 Oct 27, 2022	BUY	N/A	464,000 Added 703.03%	530,000 $531,000
Q1 2022 May 13, 2022	SELL	N/A	-56,000 Reduced 9.56%	530,000 $531,000
Q4 2021 Feb 14, 2022	BUY	N/A	5,000 Added 0.86%	586,000 $611,000
Q3 2021 Nov 15, 2021	BUY	N/A	581,000 New	581,000 $575,000

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.